Elotuzumab in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma

Sagar Lonial, Ravi Vij, Jean Luc Harousseau, Thierry Facon, Philippe Moreau, Amitabha Mazumder, Jonathan L. Kaufman, Xavier Leleu, L. Claire Tsao, Christopher Westland, Anil K. Singhal, Sundar Jagannath

Research output: Contribution to journal › Article › peer-review

257 Scopus citations

Fingerprint

Dive into the research topics of 'Elotuzumab in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology